SEC 13F Intelligence

Quadrature Capital Ltd / ELV

Quadrature Capital Ltd’s Elevance Health Inc Formerly Position

Does Quadrature Capital Ltd own Elevance Health Inc Formerly (ELV)? Yes47.3K shares worth $14M (+0.16% of its 13F portfolio) as of Q1 2026, down from 52.8K shares the prior filed quarter.

Position Value
$14M
Q1 2026
Shares
47.3K
% of Portfolio
+0.16%
Quarters Held
21
currently held

Position History ELV

Reported value by quarter
Q4 ’18: $1MQ4 ’18Q1 ’19: $15MQ3 ’19: $19MQ2 ’20: $6MQ2 ’20Q3 ’20: $9MQ1 ’21: $5MQ2 ’21: $3MQ2 ’21Q3 ’22: $8MQ4 ’22: $19MQ1 ’23: $44MQ1 ’23Q2 ’23: $47MQ3 ’23: $41MQ4 ’23: $12MQ4 ’23Q1 ’24: $5MQ2 ’24: $8MQ3 ’24: $12MQ3 ’24Q4 ’24: $118MQ2 ’25: $30MQ3 ’25: $38MQ3 ’25Q4 ’25: $19MQ1 ’26: $14Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202647.3K$14M+0.16%
Q4 202552.8K$19M+0.19%
Q3 2025116.9K$38M+0.45%
Q2 202577.2K$30M+0.52%
Q4 2024320.0K$118M+2.36%
Q3 202422.6K$12M+0.27%
Q2 202414.4K$8M+0.13%
Q1 202410.1K$5M+0.09%
Q4 202326.1K$12M+0.23%
Q3 202393.9K$41M+0.87%
Q2 2023106.0K$47M+1.08%
Q1 202396.4K$44M+1.29%
Q4 202237.5K$19M+0.60%
Q3 202217.7K$8M+0.28%
Q2 20216.6K$3M+0.10%
Q1 202113.6K$5M+0.24%
Q3 202032.4K$9M+0.51%
Q2 202022.7K$6M+0.66%
Q3 201979.2K$19M+0.92%
Q1 201952.0K$15M+1.29%
Q4 20185.4K$1M+0.26%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Quadrature Capital Ltd’s full portfolio or all institutional holders of ELV.